RETRACTION: The Expression of Tuftelin 1 as a New Theranostic Marker in Early Diagnosis and as a Therapeutic Target in Hepatocellular Carcinoma
Cell Biochemistry and Function · 2026-11 · 44 (11)
DOI: 10.1002/cbf.70342 ↗At a glance
Journal article in Cell Biochemistry and Function, published online on 2026-11-03.
Abstract (original language)
RETRACTION: N.M. Abdel‐Hamid, S.M. Zakaria, A.M. Ansary, F.F. El‐Senduny and M.M. El‐Shishtawy, “The Expression of Tuftelin 1 as a New Theranostic Marker in Early Diagnosis and as a Therapeutic Target in Hepatocellular Carcinoma,” Cell Biochemistry and Function 41, no. 7 (2023): 788‐800, https://doi.org/10.1002/cbf.3828 . The above article, published online on 20 July 2023 in Wiley Online Library ( wileyonlinelibrary.com ), has been retracted by agreement between the journal Editor‐in‐Chief, Robert Heath; and John Wiley & Sons Ltd. The retraction has been agreed upon following concerns raised by a third party. An investigation found duplications between Figures 2I and 4I, and between Figures 3AI and 5AI. In addition, four TUFT1 western blot bands in Figure 5BI appear to have been duplicated from a previous article published by one of the same authors, where they were presented as representing a different target protein. The authors stated that the duplicated panels in Figures 2I and 4I, and 3AI and 5AI, represented the same normal control groups. However, as Figures 2 and 4, and Figures 3 and 5, relate to separate experiments, and the reuse of control images was not disclosed in the article, the editor did not consider this explanation satisfactory. The authors also stated that the western blot shown in Figure 5BI had been generated by an external laboratory but were unable to explain the duplication with the previously published article. As a result, the editor concluded that the reliability of the reported findings could not be assured and the article is therefore being retracted.
Cite
APA
(2026). RETRACTION: The Expression of Tuftelin 1 as a New Theranostic Marker in Early Diagnosis and as a Therapeutic Target in Hepatocellular Carcinoma. Cell Biochemistry and Function, 44(11). https://doi.org/10.1002/cbf.70342
Vancouver
RETRACTION: The Expression of Tuftelin 1 as a New Theranostic Marker in Early Diagnosis and as a Therapeutic Target in Hepatocellular Carcinoma. Cell Biochemistry and Function. 2026;44(11). doi:10.1002/cbf.70342
BibTeX
@article{euvimed2026,
title = {RETRACTION: The Expression of Tuftelin 1 as a New Theranostic Marker in Early Diagnosis and as a Therapeutic Target in Hepatocellular Carcinoma},
journal = {Cell Biochemistry and Function},
year = {2026},
volume = {44},
number = {11},
doi = {10.1002/cbf.70342}
}
EUVIMED